Assessment of the Impact of National Guidelines on Uptake of a Biomarker Among HCPs and Payers

Home / Intelligence / Case Studies / Assessment of the Impact of National Guidelines on Uptake of a Biomarker Among HCPs and Payers

Trinity designed staggered quantitative research to assess the impact of national guidelines on uptake of a biomarker among HCPs and payers.

Geographic Scope:

Client Situation

The client wanted to understand the impact of national physician society guidelines on uptake / acceptance of an innovative biomarker based on developed patient vignettes, and expectations for updates to payer diagnostic testing polices.

Trinity’s Solution

Trinity conducted qualitative research, fielding a survey with physicians and payers, to determine current physician utilization and payer coverage of biomarker diagnostic test and track evolution in payer policies and physician utilization with Wave II of the survey 6 – 12 months later.


  • Interim findings of current physician utilization and payer coverage of the biomarker diagnostic test
  • Final deliverable presenting the impact of the guidance on physicians and payers and providing recommendations to improve perception of the biomarker

Project Outcomes & Impact

Research findings helped the brand team to understand how the disease landscape will evolve as availability and adoption of the biomarker expands in the market, and then track this evolution on a longitudinal basis.

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email